文献速递妇科

子宫肌瘤中神经源性因子表达增加

Increased expression of neurogenic factors in uterine fibroids.
PubMed 文献 · Hum Reprod · 2019-01-01

该实验室病例对照研究于2015至2017年纳入15例生殖年龄增殖期女性的肌瘤、配对肌层及在位内膜,并取15例卵巢囊肿手术者的对照内膜。结果显示NGF、MAP-2、SYP mRNA在肌瘤中显著高于配对肌层(P<0.05),仅NGF在在位内膜显著升高;TNF处理可显著上调原代平滑肌细胞中三者mRNA(P<0.05)。

要点

  • NGF、MAP-2、SYP mRNA在子宫肌瘤中显著高于配对肌层(P<0.05)。
  • 在位内膜仅NGF显著高于健康内膜,MAP-2、SYP无显著差异。
  • TNF处理显著上调肌瘤及配对肌层来源原代平滑肌细胞NGF、MAP-2、SYP mRNA(P<0.05)。

核心结论

  • 子宫肌瘤中神经源性因子NGF、MAP-2、SYP高表达,且TNFα可上调培养平滑肌细胞中该神经源性通路。
  • 肌瘤在位内膜中NGF表达升高,患者内膜基质细胞TNF表达高于对照(P<0.001)。
  • 作者认为这些神经源性通路可能成为治疗肌瘤相关疾病的潜在靶点。

研究设计与样本

  • 实验室病例对照研究,2015至2017年纳入15例生殖年龄增殖期女性的肌瘤、配对肌层及在位内膜。
  • 对照内膜取自因卵巢囊肿手术的女性(n=15)。
  • 方法包括qRT-PCR、蛋白质印迹和免疫染色,并分析TNF对原代平滑肌细胞的影响。

主要发现

  • qRT-PCR显示NGF、MAP-2、SYP mRNA在肌瘤中显著高于配对肌层(P<0.05)。
  • 在位内膜仅NGF显著高于健康内膜,MAP-2和SYP无显著差异。
  • TNF处理显著上调肌瘤及配对肌层来源原代平滑肌细胞NGF、MAP-2、SYP mRNA(P<0.05)。
  • 肌瘤患者内膜基质细胞TNF表达显著高于对照(P<0.001)。

关键数值与推荐

  • qRT-PCR与免疫荧光验证显示肌瘤中神经源性因子明确上调。
  • NGF、MAP-2、SYP mRNA在肌瘤 vs 配对肌层比较中P<0.05。
  • TNF处理前后原代平滑肌细胞NGF、MAP-2、SYP mRNA比较P<0.05。
  • 肌瘤患者内膜基质细胞TNF表达 vs 对照P<0.001。

临床怎么用

  • 原文未据此给出临床推荐。
  • 作者认为神经源性因子在肌瘤和内膜中表达增加可能解释疼痛刺激。
  • 作者认为这些神经源性通路可能成为治疗肌瘤相关疾病的潜在治疗途径。

局限性

  • 原文指出需额外研究确立神经元基因表达增加与疼痛程度之间的相关性。
  • 原文指出需额外研究炎症介质参与神经源性异常的发生。
  • 原文指出需更多体内研究确认原代培养平滑肌细胞所得结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Are selective markers for the neuronal differentiation such as microtubule-associated protein 2 (MAP-2) and synaptophysin (SYP) as well as the nerve growth factor (NGF) expressed by fibroids, myometrium and eutopic endometrium? SUMMARY ANSWER: Neuronal markers NGF, MAP-2 and SYP are highly expressed in fibroids compared with matched myometrium, and this neurogenic pathway is upregulated by tumor necrosis factor (TNF) alpha in cultured smooth muscle cells (SMCs). WHAT IS KNOWN ALREADY: Uterine fibroids or leiomyomas are the most common benign tumors, accounting for approximately one-third of hysterectomies. The present trend is to improve the medical treatment avoiding surgery, also for fertility sparing; hence, the pathogenic mechanisms are investigated, aiming to develop new therapeutic strategy. STUDY DESIGN, SIZE, DURATION: This laboratory-based case-control study is focused on fibroids and myometrial specimens obtained between 2015 and 2017 from 15 women of reproductive age at the proliferative phase of the menstrual cycle. Leiomyomas, matched myometrium and endometrium from each woman were analyzed. Control endometrium was obtained from women undergoing surgery for ovarian cyst (n = 15). PARTICIPANTS/MATERIALS, SETTING, METHODS: qRT-PCR, western blotting and immunostaining were applied to evaluate the expression of neurogenic markers; the effects of TNF on NGF, MAP-2 and SYP expression in cultured SMCs from leiomyomas and matched myometrium were analyzed. MAIN RESULTS AND THE ROLE OF CHANCE: qRT-PCR analyses using tissues from clinical patients showed that the levels of NGF, MAP-2 and SYP mRNA were significantly higher in uterine leiomyomas compared with their matched myometrium (P < 0.05), whereas only NGF was significantly increased in eutopic endometrium compared with healthy endometrium. In primary SMCs, isolated from fibroids or from the adjacent myometrium, NGF, MAP-2 and SYP mRNA expression were significantly increased by TNF treatment (P < 0.05). Finally, human endometrial stromal cells prepared from the endometrium of patients affected by uterine fibroids display higher TNF expression (P < 0.001). LIMITATIONS, REASONS FOR CAUTION: qRT-PCR analysis and immunofluorescence validation are robust methods demonstrating a clear upregulation of neurogenic factors in leiomyomas, even though additional studies are needed to establish a correlation between increased neuronal gene expression and degree of pain, as well as the involvement of inflammation mediators in the development of the neurogenic unhinge. Therefore, more in vivo studies are needed to confirm the results achieved from primary cultured SMCs. WIDER IMPLICATIONS OF THE FINDINGS: The increased expression of neurogenic factors in uterine fibroids and endometrium may contribute to explain the painful stimuli. Accordingly, these neurogenic pathways may represent potential therapeutic avenues to treat the fibroid-related disorders. STUDY FUNDING/COMPETING INTEREST(S): This study was supported by research grants from the University of Siena. The authors declare no conflict of interest. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Luddi A, Marrocco C, Governini L, et al. Increased expression of neurogenic factors in uterine fibroids. Hum Reprod. 2019. PMID: 31732726. doi:10.1093/humrep/dez182

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。